$TBMC
Trailblazer Merger Corp I Stock $tbmc

$tbmc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024100171 Filed on November 19, 2024

Income Statement

Concept	2024 Q3
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$532.9K
YoY Change	174.57%
Operating Profit	-$532.8K
YoY Change	174.57%
Interest Expense	$878.1K
YoY Change	-1.81%
% of Operating Profit
Other Income/Expense, Net	$878.1K
YoY Change	-1.81%
Pretax Income	$345.3K
YoY Change	-50.7%
Income Tax	$199.9K
% Of Pretax Income	57.91%
Net Earnings	$145.3K
YoY Change	-72.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.02
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$108.5K
YoY Change	-83.94%
Cash & Equivalents	$108.5K
Short-Term Investments
Other Short-Term Assets	$50.21M
YoY Change	34308.97%
Inventory
Prepaid Expenses	$77.81K
Receivables
Other Receivables
Total Short-Term Assets	$50.31M
YoY Change	6025.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.85M
YoY Change	-62.71%
Other Assets	$0.00
YoY Change	-100.0%
Total Long-Term Assets	$26.85M
YoY Change	-62.74%
TOTAL ASSETS
Total Short-Term Assets	$50.31M
Total Long-Term Assets	$26.85M
Total Assets	$77.16M
YoY Change	5.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$803.4K
YoY Change	260.26%
Accrued Expenses	$803.4K
YoY Change	971.17%
Deferred Revenue
YoY Change
Short-Term Debt	$2.280M
YoY Change	601.34%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.08M
YoY Change	5690.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$2.070M
YoY Change	0.0%
Total Long-Term Liabilities	$2.070M
YoY Change	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.08M
Total Long-Term Liabilities	$2.070M
Total Liabilities	$56.15M
YoY Change	1769.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.999M
YoY Change	218.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.998M
YoY Change
Total Liabilities & Shareholders Equity	$77.16M
YoY Change	5.89%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	$145.3K
YoY Change	-72.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$479.8K
YoY Change	736.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$353.4K
YoY Change
Cash From Investing Activities	$353.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K
YoY Change	-13003.23%
NET CHANGE
Cash From Operating Activities	-479.8K
Cash From Investing Activities	353.4K
Cash From Financing Activities	200.0K
Net Change In Cash	73.56K
YoY Change	-224.93%
FREE CASH FLOW
Cash From Operating Activities	-$479.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41668
	dei	Entity Registrant Name EntityRegistrantName	TRAILBLAZER MERGER CORPORATION I
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3710376
	dei	Entity Address Address Line1 EntityAddressAddressLine1	510 Madison Avenue Suite 1401
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	586-8224
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108520	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	607816	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	353388	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	77806	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	141937	usd
CY2024Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	49774936	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	50314650	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	749753	usd
CY2023Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	25681	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	26845950	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	72994863	usd
CY2024Q3	us-gaap	Assets Assets	77160600	usd
CY2023Q4	us-gaap	Assets Assets	73770297	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	803378	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	238834	usd
CY2023Q4	tbmcu	Accrued Offering Costs Current AccruedOfferingCostsCurrent	75000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1102538	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	306834	usd
CY2024Q3	tbmcu	Excise Tax Payable Current ExciseTaxPayableCurrent	497749	usd
CY2024Q3	tbmcu	Class A Common Stock Pending Redemption ClassACommonStockPendingRedemption	4520384	shares
CY2023Q4	tbmcu	Class A Common Stock Pending Redemption ClassACommonStockPendingRedemption	4520384	shares
CY2024Q3	tbmcu	Class A Common Stock Pending Redemptions ClassACommonStockPendingRedemptions	49774936	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	54080186	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	942253	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	210152	usd
CY2024Q3	tbmcu	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	2070000	usd
CY2023Q4	tbmcu	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	2070000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	56150186	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3222405	usd
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2379616	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6900000	shares
CY2024Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.93
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.47
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	26008867	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	72224950	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4998665	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1677270	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4998453	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1677058	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77160600	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73770297	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	532847	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	194068	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1493646	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	432659	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-532847	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-194068	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1493646	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-432659	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	207087	usd
CY2024Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	883635	usd
CY2023Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	834276	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	2814405	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1632278	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-5531	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	60048	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-21578	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	878104	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	894324	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2814405	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1403613	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	345257	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	700256	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1320759	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	970954	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	199929	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	177308	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	585552	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306725	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	145328	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	522948	usd
	us-gaap	Net Income Loss NetIncomeLoss	735207	usd
	us-gaap	Net Income Loss NetIncomeLoss	664229	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1677058	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-1400699	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	372368	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2705389	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-1437975	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	217511	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3925853	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-720179	usd
CY2024Q3	tbmcu	Excise Tax Payables Attributable To Redemption Of Class A Common Stock ExciseTaxPayablesAttributableToRedemptionOfClassACommonStock	-497749	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	145328	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4998453	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	19813	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	394500	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3945000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	207087	usd
CY2023Q1	tbmcu	Adjustmentto Additional Paid In Capital Fair Value Of Rights Included In Public Units AdjustmenttoAdditionalPaidInCapitalFairValueOfRightsIncludedInPublicUnits	745200	usd
CY2023Q1	tbmcu	Adjustmentto Additional Paid In Capital Allocated Value Of Transaction Costs To Class A Shares AdjustmenttoAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToClassAShares	-89233	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-6007229	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-249591	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1428953	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-386959	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	390872	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1425040	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-667016	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	522948	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1569108	usd
	us-gaap	Net Income Loss NetIncomeLoss	735207	usd
	us-gaap	Net Income Loss NetIncomeLoss	664229	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	207087	usd
	tbmcu	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	2814405	usd
	tbmcu	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	1632278	usd
	tbmcu	Unrealized Loss On Marketable Securities Held In Trust Account UnrealizedLossOnMarketableSecuritiesHeldInTrustAccount	-21578	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-210152	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-4123	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-64131	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	143822	usd
	us-gaap	Increase Decrease In Prepaid Insurance IncreaseDecreaseInPrepaidInsurance	-25681	usd
	us-gaap	Increase Decrease In Prepaid Insurance IncreaseDecreaseInPrepaidInsurance	52556	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	564544	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	221709	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	795704	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	310848	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-839290	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-407328	usd
	tbmcu	Proceeds From Cash Withdrawn From Trust Account To Pay Franchise Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseTaxes	568382	usd
	tbmcu	Paymentto Investment Of Cash Into Trust Account PaymenttoInvestmentOfCashIntoTrustAccount	70380000	usd
	tbmcu	Extension Deposit Into Trust Account ExtensionDepositIntoTrustAccount	1380000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-811618	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70380000	usd
	tbmcu	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid	67965000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3945000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1580000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100085	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	581635	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1505000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71428450	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-145908	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	641122	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	607816	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34393	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	461908	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	675515	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108520	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	675515	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	353388	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	461908	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	675515	usd
	tbmcu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	3558853	usd
	tbmcu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	7061204	usd
	tbmcu	Excise Tax Payable ExciseTaxPayable	497749	usd
	tbmcu	Pending Redemptions Of Class A Common Shares PendingRedemptionsOfClassACommonShares	49774936	usd
	tbmcu	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	75000	usd
	tbmcu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2070000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trailblazer Merger Corporation I (the “Company”, “we”) is a blank check company incorporated in Delaware on November 12, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company has two subsidiaries, Trailblazer Merger Sub Ltd, an Israeli company and a direct, wholly owned subsidiary of the Company incorporated on June 25, 2024, and Trailblazer Holdings, Inc. (“Holdings”), a Delaware corporation and a direct, wholly owned subsidiary of the Company incorporated on July 16, 2024. Holdings will be the public company following the closing of the Business Combination. The Business Combination transaction is structured as follows: (a) the Company shall merge with and into Holdings and Holdings shall be the survivor of such merger and (b) the merger subsidiary of the Company shall merge with and into the target, Cyabra Strategy Ltd. (“Cyabra”), with Cyabra being the surviving entity, following which the merger subsidiary will cease to exist and Cyabra will become a wholly owned subsidiary of Holdings. As of September 30, 2024, the two subsidiaries had no financial activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company has not yet commenced any operations. All activity for the period November 12, 2021 (inception) through September 30, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement for the Company’s Initial Public Offering was declared effective on March 28, 2023. On March 31, 2023, the Company consummated the Initial Public Offering of 6,900,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units being offered, the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 900,000 Units, at $10.00 per Unit, generating gross proceeds of $69,000,000 which is described in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 394,500 units (the “Placement Units”) at a price of $10.00 per Placement Unit, in a private placement to Trailblazer Sponsor Group, LLC (the “Sponsor”), generating gross proceeds of $3,945,000, which is described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction costs amounted to $3,971,262 consisting of $1,035,000 of cash underwriting discount, $2,070,000 of deferred underwriting fees, and $866,262 of other offering costs. The allocated value of transaction costs to Class A common stock amounted to $89,233.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Initial Public Offering on March 31, 2023, an amount of $70,380,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940. There is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Company seeks stockholder approval, it will only proceed with a Business Combination, if a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), which will be filed prior to the Initial Public Offering, increase the number of authorized shares, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), placement shares (shares of Class A common stock included in the Placement Units) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period, as defined below, and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through September 30, 2024, the Sponsor deposited a total of $1,380,000 (the “Extension Payment”) into the Company’s Trust Account in order to extend the date by which the Company has to consummate a business combination from March 31, 2024 to September 30, 2024. The Extension Payment was loaned as a draw down pursuant to an unsecured promissory note the Company issued to the Sponsor (see Note 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As approved by its stockholders at the annual meeting of stockholders held on September 26, 2024 (the “Annual Meeting”), the Company filed an amendment to its Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on September 27, 2024 (the “Charter Amendment”), and also amended its investment management trust agreement, to (a) modify the terms and extend the date (the “Termination Date”) by which the Company has to consummate a business combination by allowing the Company, through resolution of the board of directors without another stockholder vote, to elect to extend the Termination Date by one month each time from September 30, 2024 to September 30, 2025 (the “Combination Period”), or such earlier date as determined by the Board in its sole discretion, unless the closing of a business combination shall have occurred prior thereto; and (b) to remove the provision which permitted the withdrawal of $100,000 from the trust account of the Company in order to pay dissolution expenses. For each monthly extension approved by the Board, the monthly payment required to be deposited into the Company’s Trust Account to extend the Termination Date by one month should be the lesser of (i) $0.035 for each outstanding share of Public Stock after giving effect to the redemption, and (ii) $100,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the stockholders’ vote at the Annual Meeting, 4,520,384 shares were tendered for redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 2, 2024, the Sponsor deposited $83,287 into the Company’s Trust Account to extend the Termination Date from September 30, 2024 to October 30, 2024 (see Note 9).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2024, $49,774,936, or approximately $11.01 redemption price per share, was withdrawn from the Trust Account to pay the redeeming holders and the 4,520,384 shares of the Company’s Class A common stock that were redeemed were cancelled (see Note 9).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 31, 2024, the Sponsor deposited $83,287 into the Company’s Trust Account to extend the Termination Date from October 30, 2024 to November 30, 2024 (see Note 9).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Company is unable to complete a Business Combination within Termination Date (September 30, 2025, if extended by the full amount of time), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.20 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay our taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Going Concern Consideration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor issuance of Founder Shares and loan proceeds from the Sponsor under the Promissory Note (as defined in Note 5). Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the Initial Public Offering and the sale of the Placement Units in a private placement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, it would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Placement Units. As of September 30, 2024 and December 31, 2023, there were no amount outstanding under the Working Capital Loan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. In addition, the Company has until November 30, 2024, as extended, to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by November 30, 2024 (September 30, 2025, if extended by the full amount of time), there will be a mandatory liquidation and subsequent dissolution. Management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution and the liquidity issue raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 30, 2024 (September 30, 2025, if extended by the full amount of time). The Company intends to complete a Business Combination with Cyabra (see Note 6) before the mandatory liquidation date. The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Quarterly Report on Form 10-Q.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inflation Reduction Act of 2022</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the second quarter of 2024, the Internal Revenue Service issued final regulations with respect to the timing and payment of the Excise Tax. These regulations provided that the filing and payment deadline for any liability incurred during the period from January 1, 2023 to December 31, 2023 would be October 31, 2024. Any amount of such Excise Tax not paid in full, will be subject to additional interest and penalties which are currently estimated at 10% interest per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid from November 1, 2024 until paid in full. The Company had no common stock redemptions in 2023 and no excise tax was due on October 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company has recorded 1% excise tax payable based on the amount redeemed or an aggregate amount of $497,749 and is presented in the accompanying balance sheet.</p>
CY2024Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3971262	usd
CY2024Q3	tbmcu	Sale Of Stock Underwriting Fees SaleOfStockUnderwritingFees	1035000	usd
	tbmcu	Deferred Underwriting Fees DeferredUnderwritingFees	2070000	usd
CY2024Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	866262	usd
	tbmcu	Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount	0.80	pure
	tbmcu	Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination	0.50	pure
	tbmcu	Public Offering Price Per Share PublicOfferingPricePerShare	10.2
	tbmcu	Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent	0.15	pure
	tbmcu	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	March 31, 2024 to September 30, 2024
CY2024Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	100000	usd
CY2024Q3	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	100000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4520384	shares
	tbmcu	Working Capital WorkingCapital	1500000	usd
CY2024Q3	us-gaap	Share Price SharePrice	10
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.01	pure
CY2022Q3	tbmcu	Federal Tax Rate FederalTaxRate	0.01	pure
	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.10	pure
	tbmcu	Percentage Of Underpayment Penalty PercentageOfUnderpaymentPenalty	0.05	pure
	tbmcu	Percentage Of Total Liability PercentageOfTotalLiability	0.25	pure
	tbmcu	Percentage Of Excise Tax Payable PercentageOfExciseTaxPayable	0.01	pure
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	497749	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108520	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	607816	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	353388	usd
CY2024Q3	tbmcu	Withdraw Of Interest Earned On Trust Account WithdrawOfInterestEarnedOnTrustAccount	568382	usd
	tbmcu	Withdrawn Amount WithdrawnAmount	353388	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	69000000	usd
CY2023	tbmcu	Temporary Equity Proceeds Allocated To Public Rights TemporaryEquityProceedsAllocatedToPublicRights	-745200	usd
CY2023	tbmcu	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	-3882029	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7852179	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	72224950	usd
	tbmcu	Redemption Of Class A Common Stock RedemptionOfClassACommonStock	49774936	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	3558853	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	26008867	usd
CY2024Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	228928	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	210151	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	82679	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.579	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.253	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.443	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.316	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	tbmcu	Accrued Interest And Penalties AccruedInterestAndPenalties	26027	usd
	tbmcu	Accrued Interest And Penalties AccruedInterestAndPenalties	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	729450	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account.</p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Other Expenses OtherExpenses	3545	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1090000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1780000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1980000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2280000	usd
CY2024Q3	tbmcu	Deferred Fee Per Unit DeferredFeePerUnit	0.3
	tbmcu	Deferred Underwriting Fees DeferredUnderwritingFees	2070000	usd
	tbmcu	Underwriters Fees As Percentage Of Total Consideration UnderwritersFeesAsPercentageOfTotalConsideration	0.015	pure
CY2024Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
	tbmcu	Aggregate Amount Of Reimburse Underwriters AggregateAmountOfReimburseUnderwriters	50000	usd
	tbmcu	Reimburse Underwriters Expenses Incurred In Excess ReimburseUnderwritersExpensesIncurredInExcess	50000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2379616	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6900000	shares
CY2024Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	76620886	usd
CY2024Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	49774936	usd
CY2024Q3	tbmcu	Withdraw Of Interest Earned On Trust Accounts WithdrawOfInterestEarnedOnTrustAccounts	568382	usd
CY2024Q4	us-gaap	Subsequent Event Description SubsequentEventDescription	(i) increase the size of the Trailblazer Board from five directors to seven directors; (ii) remove the director election proposal from the Required Parent Proposals (as defined in the Merger Agreement); (iii) increase the size of the 2024 Plan from 10% to 15% due to the fact that certain previously contemplated grants will be included as part of the 2024 Plan; (iv) amend the provision related to the share grant to the Cyabra Key Employees to clarify that such grant may be subject to additional vesting conditions as agreed upon between the respective Cyabra Key Employee and Cyabra; and (v) amend the Outside Date from December 31, 2024 to March 31, 2025.
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent		usd
CY2024Q3	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent		usd
CY2024Q3	tbmcu	Accrued Offering Costs Current AccruedOfferingCostsCurrent		usd
CY2023Q4	tbmcu	Excise Tax Payable Current ExciseTaxPayableCurrent		usd
CY2023Q4	tbmcu	Class A Common Stock Pending Redemptions ClassACommonStockPendingRedemptions		usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	tbmcu	Unrealized Loss On Marketable Securities Held In Trust Account UnrealizedLossOnMarketableSecuritiesHeldInTrustAccount		usd
	tbmcu	Proceeds From Cash Withdrawn From Trust Account To Pay Franchise Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseTaxes		usd
	tbmcu	Paymentto Investment Of Cash Into Trust Account PaymenttoInvestmentOfCashIntoTrustAccount		usd
	tbmcu	Extension Deposit Into Trust Account ExtensionDepositIntoTrustAccount		usd
	tbmcu	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash		usd
	tbmcu	Excise Tax Payable ExciseTaxPayable		usd
	tbmcu	Pending Redemptions Of Class A Common Shares PendingRedemptionsOfClassACommonShares		usd
	tbmcu	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts		usd
	tbmcu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2024Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001934945

Files In Submission

Name	View Source	Status
tbmcu-20240930_lab.xml	Edgar Link	unprocessable
tbmcu-20240930_def.xml	Edgar Link	unprocessable
0001213900-24-100171-index-headers.html	Edgar Link	pending
0001213900-24-100171-index.html	Edgar Link	pending
0001213900-24-100171.txt	Edgar Link	pending
0001213900-24-100171-xbrl.zip	Edgar Link	pending
ea0219048-10q_trailblazer1.htm	Edgar Link	pending
ea021904801ex31-1_trailblaz1.htm	Edgar Link	pending
ea021904801ex31-2_trailblaz1.htm	Edgar Link	pending
ea021904801ex32-1_trailblaz1.htm	Edgar Link	pending
ea021904801ex32-2_trailblaz1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tbmcu-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0219048-10q_trailblazer1_htm.xml	Edgar Link	completed
tbmcu-20240930_cal.xml	Edgar Link	unprocessable
tbmcu-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TBMC
Trailblazer Merger Corp I Stock $tbmc

2024 Q3 Form 10-Q Financial Statement

#000121390024100171 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBMC Trailblazer Merger Corp I Stock $tbmc

2024 Q3 Form 10-Q Financial Statement

#000121390024100171 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBMC
Trailblazer Merger Corp I Stock $tbmc